Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,244 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $348.17 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $150.00 | 1 | $0 (2024) |
| GENZYME CORPORATION | $128.55 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $121.16 | 1 | $0 (2024) |
| Averitas Pharma Inc. | $115.42 | 1 | $0 (2024) |
| Dexcom, Inc. | $108.32 | 1 | $0 (2023) |
| Abbott Laboratories | $104.58 | 1 | $0 (2023) |
| Stryker Corporation | $43.09 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $617.11 | 5 | Bayer Healthcare Pharmaceuticals Inc. ($150.00) |
| 2023 | $252.90 | 3 | Dexcom, Inc. ($108.32) |
| 2022 | $256.04 | 3 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2021 | $118.24 | 1 | Novo Nordisk Inc ($118.24) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.16 | General |
| 09/07/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $128.55 | General |
| Category: Rheumatology | ||||||
| 08/01/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $115.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardio-renal | ||||||
| 02/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $101.98 | General |
| Category: Obesity | ||||||
| 09/29/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 06/03/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $108.32 | General |
| Category: Endocrinology | ||||||
| 03/02/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $104.58 | General |
| Category: Diabetes Care | ||||||
| 11/03/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $87.95 | General |
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2022 | Stryker Corporation | TRIATHLON (Device) | Food and Beverage | In-kind items and services | $43.09 | General |
| Category: KNEES | ||||||
| 11/04/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $118.24 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 616 | 991 | $96,073 | $26,924 |
| 2022 | 13 | 612 | 947 | $74,504 | $21,152 |
| 2021 | 11 | 709 | 1,017 | $103,540 | $31,252 |
| 2020 | 10 | 565 | 856 | $79,267 | $23,833 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 46 | 47 | $235.00 | $77.36 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 111 | 146 | $25,380 | $7,996 | 31.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 118 | 118 | $25,445 | $6,726 | 26.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 99 | 118 | $16,542 | $4,687 | 28.3% |
| 73562 | X-ray of knee, 3 views | Office | 2021 | 101 | 141 | $10,776 | $3,452 | 32.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $9,151 | $2,903 | 31.7% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 66 | 87 | $5,589 | $1,794 | 32.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 102 | 277 | $3,878 | $1,486 | 38.3% |
| 72170 | X-ray of pelvis, 1 or 2 views | Office | 2021 | 37 | 43 | $2,350 | $731.33 | 31.1% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2021 | 24 | 24 | $1,828 | $580.36 | 31.7% |
| 73100 | X-ray of wrist, 2 views | Office | 2021 | 11 | 22 | $1,430 | $493.90 | 34.5% |
| 73502 | X-ray of hip with pelvis, 2-3 views | Office | 2021 | 12 | 13 | $1,171 | $401.31 | 34.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 98 | 98 | $20,482 | $5,665 | 27.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 107 | 143 | $19,352 | $5,393 | 27.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 96 | 110 | $15,860 | $4,374 | 27.6% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2020 | 12 | 28 | $8,036 | $3,089 | 38.4% |
| 73562 | X-ray of knee, 3 views | Office | 2020 | 78 | 104 | $7,072 | $2,237 | 31.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2020 | 48 | 60 | $3,300 | $1,272 | 38.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2020 | 87 | 247 | $3,458 | $1,238 | 35.8% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2020 | 13 | 13 | $871.00 | $325.26 | 37.3% |
| 72170 | X-ray of pelvis, 1 or 2 views | Office | 2020 | 13 | 13 | $793.00 | $223.54 | 28.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2020 | 13 | 40 | $42.60 | $16.70 | 39.2% |
About Evy Gonzalez, FNP
Evy Gonzalez, FNP is a Family healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1730358490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Evy Gonzalez, FNP has received a total of $1,244 in payments from pharmaceutical and medical device companies, with $617.11 received in 2024. These payments were reported across 12 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,244).
As a Medicare-enrolled provider, Gonzalez has provided services to 2,502 Medicare beneficiaries, totaling 3,811 services with total Medicare billing of $103,161. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Weslaco, TX
- Active Since 02/27/2008
- Last Updated 10/25/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1730358490
Products in Payments
- Kerendia (Drug) $150.00
- KEVZARA (Biological) $128.55
- LOKELMA (Drug) $125.00
- Ozempic (Drug) $118.24
- QUTENZA (Drug) $115.42
- DEXCOM G7 GSS (161) (Medical Supply) $108.32
- FREESTYLE LIBRE 3 (Device) $104.58
- Wegovy (Drug) $101.98
- TRIATHLON (Device) $43.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Weslaco
Pamela Lopez, Aprn-Bc, Cde, APRN-BC, CDE
Family — Payments: $17,229
Nora Medina
Family — Payments: $4,170
Margarita Rodriguez, Fnp, FNP
Family — Payments: $3,773
Francisco Lugo
Family — Payments: $2,538
Mr. Jesus Guerra, Fnp, FNP
Family — Payments: $2,171
Belinda Aguilar, Fnp-C, FNP-C
Family — Payments: $1,702